18 May 2013
20 April 1992
In the pharmaceutical sector, research and development spending is now so "repressive" that there is little chance of a reasonable...
20 April 1992
The Association of the British Phar-maceutical Industry has called for more stringent controls on imported pharmaceuticals, although admitting that National...
20 April 1992
The Imex Hemofarm pharmaceutical concern based in Vrsac in Serbia has opened a representative office in Moscow in order to...
20 April 1992
New sales and earnings records were achieved by the US pharmaceutical concern Bristol-Myers Squibb in 1991, according to its annual...
20 April 1992
Japanese pharmaceutical companies must be regarded as world market competitors more speedily than had originally been expected, according to Hans...
20 April 1992
Yediot Aharonot, Israel's leading daily newspaper, has published results of a survey by the Brendman Institute into Israeli public attitudes...
20 April 1992
EUROPE: saw most of its stock markets down on the week, following the free-fall in Tokyo and poor performance of...
20 April 1992
The role of the German drug law in possibly creating conditions where drugs can be modified and marketed without regulatory...
20 April 1992
Robert Steinman has been named as president of non-prescription drug company Sterling Health Canada.
20 April 1992
Etienne Attar has been promoted to vice president, sales and marketing at Ayerst Laborat-ories in Canada. He succeeds Jeff Boily,...